DRIO DarioHealth Corp.

$6.89 -5.36%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

DarioHealth Corp. (DRIO) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $68 million. Shares last traded at $6.89, 60.7% below their 52-week high. Net profit margin is -169.9%, below the peer median of -9.3%. Revenue declined 17.3% year over year.

Market Cap

$68M

Shares Out

9.8M

EPS (TTM)

$18.55

P/E Ratio

0.37

P/S Ratio

3.22

P/B Ratio

1.23

Dividend / Share

—

Dividend Yield

—

52-Week High

$17.54

52-Week Low

$0.42

Volume

321

Avg Vol (3m)

748.429

Performance

+0.58%

-9.93%

-7.02%

-40.19%

YTD

-34.91%

—

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.88

SMA (50)

$7.15

SMA (200)

$9.39

Price vs SMA50

-3.68%

Price vs SMA200

-26.59%

ATR (14)

$0.58

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$21M

Net Income

$-36M

Gross Margin

58.2%

Operating Margin

-151.6%

Net Margin

-169.9%

Return on Equity

-64.8%

Return on Assets

-36.9%

Current Ratio

2.31

Debt / Equity

0.56

Revenue Growth (YoY)

-17.3%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$1.75	2026-08-11
Q1 2026	$1.25	2026-05-13
FY 2025	$10.12	2026-03-19
Q3 2025	$9.05	2025-11-13
Q2 2026	$6.50	2026-08-11
Q1 2026	$2.87	2026-05-13

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

DRIO vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

3.22 / 2.94 med

+10% premium

Net margin vs peers

-169.9% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.